Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2021-02-24 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Intimation of Issue of Duplicate Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about share certificate issuance and name changes, not about financial results, management changes, or capital raising. It is not a report or announcement of financial performance, nor a voting result or dividend notice. The document is a regulatory compliance communication about share certificates, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like Share Issue/Capital Change (SHA) or Director's Dealing (DIRS). The document length is short and it is a notification letter, not a report or presentation.
2021-02-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about the issuance of duplicate share certificates due to a name change of shareholders. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management and shareholder records. The content is about share certificate issuance and does not contain financial data, earnings, management changes, or other report types. It is a regulatory announcement related to share certificates but does not fit into categories like Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS) because it is about duplicate certificates, not new shares or buybacks. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories. The document length is short (1813 characters), and it is a formal notification letter, not a report or presentation.
2021-02-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about the issuance of duplicate share certificates due to a name change of shareholders. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management and shareholder records. The content is about share certificate issuance and does not contain financial data, earnings, management changes, or voting results. It is not a report or announcement of financial results, nor is it a regulatory filing about compliance or officer certification. The document is specifically about share certificates, which relates to share capital changes but not new share issues or capital raising. The closest fitting category is "Transaction in Own Shares (POS)" which covers share repurchase or issuance activities, but since this is about duplicate certificates due to name change, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a compliance-related announcement to the stock exchanges that does not fit other categories.
2021-02-24 English
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 16, 2021, addressed to stock exchanges (BSE and NSE) regarding the schedule of an investor meeting (Kotak Investors' Conference-Chasing Growth 2021) to be held on February 17, 2021. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document does not contain any financial data, detailed report, or analysis. It is an announcement of an upcoming investor presentation event rather than the presentation itself or a financial report. Given the short length (1642 characters) and the nature of the content (intimation of schedule), this fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure rather than an Investor Presentation (IP) or any other specific report type.
2021-02-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 85% confidence The document is a short notice dated February 16, 2021, addressed to stock exchanges (BSE and NSE) regarding the schedule of an investor meet (Kotak Investors' Conference-Chasing Growth 2021) to be held on February 17, 2021. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document is an announcement of an upcoming investor presentation event rather than the presentation itself or a detailed report. The length is only 1642 characters, indicating it is a brief notice rather than a full report. Therefore, the document fits best under the category of Investor Presentation (IP) as it relates to the scheduling and disclosure of an investor meeting, which is a detailed presentation for investors focusing on financials, strategy, and market position.
2021-02-16 English
Intimation of Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates and the issuance of duplicate certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39. The content is about notifying the exchanges and market participants about the lost share certificates to prevent trading in those shares. There is no financial data, earnings information, or report publication mentioned. The document is a regulatory announcement related to share certificate loss and compliance, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like share issue or director dealings.
2021-02-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.